These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 16946357)

  • 21. Impact of tobacco, alcohol and cannabis use on treatment outcomes among patients experiencing first episode psychosis: Data from the national RAISE-ETP study.
    Oluwoye O; Monroe-DeVita M; Burduli E; Chwastiak L; McPherson S; McClellan JM; McDonell MG
    Early Interv Psychiatry; 2019 Feb; 13(1):142-146. PubMed ID: 29356438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risperidone versus other antipsychotics for people with severe mental illness and co-occurring substance misuse.
    Temmingh HS; Williams T; Siegfried N; Stein DJ
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011057. PubMed ID: 29355909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug Dependence and Psychotic Symptoms: A Retrospective Study of Adolescents Who Abuse Drugs at Al-Amal Hospital in Jeddah, Saudi Arabia.
    Alibrahim O; Elawad N; Misau YA; Shaikh TM; Allam N
    J Public Health Afr; 2012 Mar; 3(1):e5. PubMed ID: 28299079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis.
    Weibell MA; Hegelstad WTV; Auestad B; Bramness J; Evensen J; Haahr U; Joa I; Johannessen JO; Larsen TK; Melle I; Opjordsmoen S; Rund BR; Simonsen E; Vaglum P; McGlashan T; McGorry P; Friis S
    Schizophr Bull; 2017 Jul; 43(4):843-851. PubMed ID: 28199703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomised controlled trial of the clinical and cost-effectiveness of a contingency management intervention compared to treatment as usual for reduction of cannabis use and of relapse in early psychosis (CIRCLE): a study protocol for a randomised controlled trial.
    Johnson S; Sheridan Rains L; Marwaha S; Strang J; Craig T; Weaver T; McCrone P; King M; Fowler D; Pilling S; Marston L; Omar RZ; Craig M; Hinton M
    Trials; 2016 Oct; 17(1):515. PubMed ID: 27770820
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychotic relapse and associated factors among patients attending health services in Southwest Ethiopia: a cross-sectional study.
    Fikreyesus M; Soboka M; Feyissa GT
    BMC Psychiatry; 2016 Oct; 16(1):354. PubMed ID: 27765033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effect of Paternal Age on Relapse in First-Episode Schizophrenia.
    Hui CL; Chiu CP; Li YK; Law CW; Chang WC; Chan SK; Lee EH; Sham P; Chen EY
    Can J Psychiatry; 2015 Aug; 60(8):346-53. PubMed ID: 26454556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A qualitative study of career exploration among young adult men with psychosis and co-occurring substance use disorder.
    Luciano A; Carpenter-Song EA
    J Dual Diagn; 2014; 10(4):220-5. PubMed ID: 25391280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of cannabis use on clinical outcomes in recent onset psychosis.
    Barrowclough C; Gregg L; Lobban F; Bucci S; Emsley R
    Schizophr Bull; 2015 Mar; 41(2):382-90. PubMed ID: 25011381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treated incidence and baseline characteristics of substance induced psychosis in a Norwegian catchment area.
    Weibell MA; Joa I; Bramness J; Johannessen JO; McGorry PD; Ten Velden Hegelstad W; Larsen TK
    BMC Psychiatry; 2013 Nov; 13():319. PubMed ID: 24279887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathways from cannabis to psychosis: a review of the evidence.
    Burns JK
    Front Psychiatry; 2013 Oct; 4():128. PubMed ID: 24133460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substance abuse and smoking among a Canadian cohort of first episode psychosis patients.
    Deruiter WK; Cheng C; Gehrs M; Langley J; Dewa CS
    Community Ment Health J; 2013 Dec; 49(6):815-21. PubMed ID: 23775243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for substance use disorders in first-episode psychosis: implications for readmission.
    Batalla A; Garcia-Rizo C; Castellví P; Fernandez-Egea E; Yücel M; Parellada E; Kirkpatrick B; Martin-Santos R; Bernardo M
    Schizophr Res; 2013 May; 146(1-3):125-31. PubMed ID: 23517662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review.
    Ochoa S; Usall J; Cobo J; Labad X; Kulkarni J
    Schizophr Res Treatment; 2012; 2012():916198. PubMed ID: 22966451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Potential Role of Long-acting Injectable Antipsychotics in People with Schizophrenia and Comorbid Substance Use.
    Koola MM; Wehring HJ; Kelly DL
    J Dual Diagn; 2012; 8(1):50-61. PubMed ID: 22754405
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis of self-reported substance use compared with laboratory substance assay in general adult mental health settings.
    Large MM; Smith G; Sara G; Paton MB; Kedzior KK; Nielssen OB
    Int J Methods Psychiatr Res; 2012 Jun; 21(2):134-48. PubMed ID: 22367926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does change in cannabis use in established psychosis affect clinical outcome?
    Barrowclough C; Emsley R; Eisner E; Beardmore R; Wykes T
    Schizophr Bull; 2013 Mar; 39(2):339-48. PubMed ID: 22037770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substance use disorder among people with first-episode psychosis: a systematic review of course and treatment.
    Wisdom JP; Manuel JI; Drake RE
    Psychiatr Serv; 2011 Sep; 62(9):1007-12. PubMed ID: 21885577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes.
    Sevy S; Robinson DG; Sunday S; Napolitano B; Miller R; McCormack J; Kane J
    Psychiatry Res; 2011 Aug; 188(3):310-4. PubMed ID: 21636134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of a working diagnosis of "psychosis" in relation to DSM-IV diagnostic criteria in a Kenyan in-patient cohort at Mathari hospital, Nairobi.
    Ndetei DM; Khasakhala LI; Ongecha FA; Mutiso V; Kokonya DA
    Afr Health Sci; 2007 Dec; 7(4):197-201. PubMed ID: 21499484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.